Cardiol Therapeutics Inc Class A
Quarterly Financials
| Values in thousands | 2024-06-30 | 2024-03-31 | 2023-09-30 |
|---|---|---|---|
Revenue | $0 | $0 | $0 |
Gross Profit | -61 | -61 | -64 |
EBITDA | -7,679 | -8,343 | -8,651 |
EBIT | -7,741 | -8,405 | -8,716 |
Net Income | -6,590 | -9,179 | -5,930 |
Net Change In Cash | 0 | 0 | 0 |
Free Cash Flow | -4,779 | -6,926 | -3,420 |
Cash | 24,021 | 28,572 | 40,540 |
Basic Shares | 68,751 | 67,259 | 64,487 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $78 | $78 |
Gross Profit | -248 | -219 | 78 | -229 |
EBITDA | -29,537 | -50,119 | -45,252 | -20,376 |
EBIT | -29,785 | -50,339 | -45,473 | -20,606 |
Net Income | -28,128 | -30,930 | -31,638 | -20,640 |
Net Change In Cash | 0 | 0 | 78 | 78 |
Free Cash Flow | -25,244 | -27,295 | -23,563 | -9,226 |
Cash | 34,869 | 59,469 | 83,899 | 14,025 |
Basic Shares | 64,463 | 62,505 | 43,222 | 29,857 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-06-30 | -$0.10 |
2024-03-31 | -$0.12 |
2023-12-31 | -$0.09 |
2023-09-30 | -$0.09 |
